Clinical Trial

Efficacy of Pregabalin for Patients With Irritable Bowel Syndrome

Recruiting
View on ClinicalTrials.gov →
Summary
To explore the efficacy of pregabalin for patients with irritable bowel syndrome (IBS).
Trial Details
NCT Number NCT07635394
Lead Sponsor Beijing Tiantan Hospital
Collaborators: Hengshui People's Hospital, Hebei Medical University Third Hospital
Conditions Irritable Bowel Syndrome (IBS)
Enrollment 258 participants
Start Date 2026-04-07
Primary Completion 2026-04-08 (estimated)
Study Completion 2029-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-09